Company Data

Akero Therapeutics Inc.

Ticker
AKRO
Current Price
$51.84 2.49%
Market Cap
$3.6B
Price Target
Refer to Report
Volume
816.6K
52wk Range
$17.86 - $58.4
Advanced Market Data

Overview

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company’s product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy